AUSTRALIA – Australian biotech giant CSL announced that the regulatory review of its US$11.7 billion acquisition of Switzerland’s Vifor Pharma been postponed as antitrust investigations continue. The acquisition will take…
Read MoreTag: Vifor Pharma
Private Equity firms mull co-bidding for Novartis generics arm
SWITZERLAND – Two private equity giants are discussing launching a joint bid for Novartis’ generics unit, Bloomberg has reported. Novartis announced last year that it was conducting a strategic review…
Read MoreBD to invest US$79 million on new R&D center in Limerick
USA – Becton Dickinson (BD) is investing US$79 million (€70 million) in a new research laboratory at its Limerick headquarters, which will create 130 jobs. The project would take five…
Read MoreCSL seals US$11.7 billion cash buyout deal of Vifor Pharma
AUSTRALIA – CSL Ltd, an Australian biopharmaceutical company, has agreed to acquire Vifor Pharma AG for US$11.7 billion (equity value) in order to diversify its business. CSL has made an…
Read More